$28.30
-0.99 (-3.38%)
Open$29.88
Previous Close$29.29
Day High$30.02
Day Low$27.83
52W High$46.95
52W Low$14.67
Volume—
Avg Volume199.3K
Market Cap93.50M
P/E Ratio—
EPS$-30.96
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.04M | 28.2K | 2.72M |
| Net Income | -94,661,469 | -1,181,711 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -106,253,381 | -1,400,261 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | — | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,168.88 | +0.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.65 | +0.07% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $151.72 | +1.48% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.87 | +0.47% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $73.00 | +2.34% | 11.5 | 30.15B |